{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:28Z","timestamp":1786991188438,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jacc.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T15:44:38Z","timestamp":1600703078000},"page":"1551-1561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion"],"prefix":"10.1016","volume":"76","author":[{"given":"So Ree","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-A","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ji","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Chol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.08.003_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4065\/81.6.835","article-title":"Oncologic emergencies: diagnosis and treatment","volume":"81","author":"Halfdanarson","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2020.08.003_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4143\/crt.2010.42.4.210","article-title":"Clinical characteristics of malignant pericardial effusion associated with recurrence and survival","volume":"42","author":"Kim","year":"2010","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jacc.2020.08.003_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/heartjnl-2019-315852","article-title":"Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes","volume":"106","author":"Imazio","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.08.003_bib4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","article-title":"Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion","volume":"66","author":"El Haddad","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.003_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-019-1190-4","article-title":"Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome","volume":"19","author":"Lutschinger","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2020.08.003_bib6","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":"COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.08.003_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.08.003_bib8","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.08.003_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10741-012-9327-x","article-title":"Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion","volume":"18","author":"Karatolios","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2020.08.003_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00059-011-3451-6","article-title":"Tumor markers in the assessment of malignant and benign pericardial effusion","volume":"36","author":"Karatolios","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2020.08.003_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/ehjci\/jey081","article-title":"Pre- and post-pericardiocentesis echo-Doppler features of effusive-constrictive pericarditis compared with cardiac tamponade and constrictive pericarditis","volume":"20","author":"Miranda","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2020.08.003_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jacc.2003.08.032","article-title":"Transient constrictive pericarditis: causes and natural history","volume":"43","author":"Haley","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.003_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mje.2002.127452","article-title":"Diagnostic value of mitral annular velocity for constrictive pericarditis in the absence of respiratory variation in mitral inflow velocity","volume":"15","author":"Ha","year":"2002","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2020.08.003_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000348559","article-title":"Malignant pericardial effusion","volume":"124","author":"Burazor","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2020.08.003_bib15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjcard.2018.06.002","article-title":"Safety and outcome of percutaneous drainage of pericardial effusions in patients with cancer","volume":"122","author":"Lekhakul","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.08.003_bib16","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.003_bib17","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2020.08.003_bib18","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A\u00a0randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.003_bib19","article-title":"Colchicine for pericarditis","volume":"8","author":"Alabed","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2020.08.003_bib20","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.003_bib21","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.2015.12763","article-title":"Evaluation and treatment of pericarditis: a systematic review","volume":"314","author":"Imazio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.08.003_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5603\/ARM.a2018.0030","article-title":"Intrapericardial cisplatin combined with oral colchicine resulted in long-term control of malignant pericardial effusion in the course of metastatic renal cancer","volume":"86","author":"Dybowska","year":"2018","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.jacc.2020.08.003_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000046519","article-title":"Colchicine: an effective treatment for refractory malignant pericardial effusion","volume":"104","author":"Ng","year":"2000","journal-title":"Acta Haematol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720362318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720362318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:36:08Z","timestamp":1760016968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720362318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0735109720362318"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.08.003","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}